High-quality products
Reliable performance
Selegiline, a monoamine oxidase (MAO) inhibitor, is FDA-approved as an adjunct treatment in the management of patients with Parkinson disease and as a treatment for a major depressive disorder (MDD) in adults.
High-quality products
Reliable performance
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping